Degarelix for treating advanced hormone-dependent prostate cancer

Final appraisal determination

Committee papers (PDF 4.21 MB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: appraisal consultation 2

Prostate cancer (advanced, hormone dependent) - degarelix depot: appraisal consultation document (PDF 199 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: committee papers information

Prostate cancer (advanced, hormone dependent) - degarelix depot: committee papers (PDF 334 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: appeal 

Prostate cancer (advanced, hormone dependent) - degarelix depot: appeal decision (PDF 303 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: notice of appeal information

Prostate cancer (advanced, hormone dependent) - degarelix depot: appeal announcement information

Ferring Pharmaceuticals Ltd

Appeals received (PDF 399 KB)

Initial scrutiny letter (PDF 95 KB)

Response to scrutiny letter (PDF 398 KB)

Final scrutiny letter (PDF 20 KB)

British Uro-Oncology Group

Appeals received (PDF 204 KB)

Initial scrutiny letter (PDF 39 KB)

Response to scrutiny letter (PDF 97 KB)

Final scrutiny letter (PDF 67 KB)

Tackle Prostate Cancer

Appeals received (PDF 74 KB)

Initial scrutiny letter (PDF 36 KB)

Response to scrutiny letter (PDF 523 KB)

Final scrutiny letter (PDF 37 KB)

Response to final scrutiny letter (PDF 243 KB)

Vice Chair of NICE's final response (PDF 17 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: registration to attend the appeal information

Prostate cancer (advanced, hormone dependent) - degarelix depot: final appraisal determination

Prostate cancer (advanced, hormone dependent) - degarelix depot: FAD document (PDF 475 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report information

Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report (PDF 4.93 MB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: appraisal consultation

Prostate cancer (advanced, hormone dependent) - degarelix depot: appraisal consultation document information

Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report information

Prostate cancer (advanced, hormone dependent) - degarelix depot: evaluation report (PDF 12.21 MB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: equality impact assessment form - scoping (PDF 122 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: response to consultee and commentator comments on the draft scope and provisional matrix (PDF 245 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: final matrix (PDF 101 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: final scope (PDF 100 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: draft scope (pre-referral) (PDF 34 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: provisional matrix (pre-referral) (PDF 34 KB)

Prostate cancer (advanced, hormone dependent) - degarelix depot: equality impact assessment guidance development (PDF 166 KB)